Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pMSCV-puro-mMcl-1 Citations (2)

Originally described in: Ubiquitin-independent degradation of antiapoptotic MCL-1.
Stewart DP, Koss B, Bathina M, Perciavalle RM, Bisanz K, Opferman JT Mol Cell Biol. 2010 Jun;30(12):3099-110. Epub 2010 Apr 12. PubMed Journal

Articles Citing pMSCV-puro-mMcl-1

Articles
Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia. Lin KH, Winter PS, Xie A, Roth C, Martz CA, Stein EM, Anderson GR, Tingley JP, Wood KC. Sci Rep. 2016 Jun 10;6:27696. doi: 10.1038/srep27696. PubMed
Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex. McNamara MC, Hosios AM, Torrence ME, Zhao T, Fraser C, Wilkinson M, Kwiatkowski DJ, Henske EP, Wu CL, Sarosiek KA, Valvezan AJ, Manning BD. iScience. 2022 Oct 28;25(11):105458. doi: 10.1016/j.isci.2022.105458. eCollection 2022 Nov 18. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.